Calcineurin Inhibitor Triple Therapy Ranks Highest for Lupus Nephritis Remission
This Bayesian network meta-analysis provides the first systematic indirect comparison of eight triple immunosuppressive regimens for active lupus nephritis induction, positioning calcineurin inhibitor based combinations at the top of the efficacy hierarchy.
📅 Journal publication: Oct 2026(online Aug 5, 2026)·Last updated: Aug 12, 2026
Triple therapy with Tacrolimus or Voclosporin excels in lupus nephritis remission.
Lupus nephritis is a severe manifestation of systemic lupus erythematosus requiring effective treatment options to achieve remission and prevent kidney damage. Triple therapy combinations, particularly SOC with Tacrolimus or Voclosporin, effectively induce remission in lupus nephritis, performing better than standard of care alone with similar safety profiles. This analysis suggests calcineurin inhibitors in triple therapy are highly effective for lupus nephritis; however, these results largely pertain to adult population data and may not wholly represent pediatric cases. Triple therapy, especially with Tacrolimus or Voclosporin, shows promise for lupus nephritis remission.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Contreras G, Mechery V, Kota S, Del Castillo Rix D, Bandes M, Dejman A, Zuo Y, Duque JC, Munoz Mendoza J
Citation:Contreras G, Mechery V, Kota S, et al. Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis. Lupus. 2026;35(12):1257-1268. doi:10.1177/09612033261474940